<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>medical &#8211; AM Biotech</title>
	<atom:link href="https://en.ambiotech.asia/tag/medical/feed/" rel="self" type="application/rss+xml" />
	<link>https://en.ambiotech.asia</link>
	<description>Targeted Exosome R&#38;D &#38; Manufacturing</description>
	<lastBuildDate>Thu, 23 Oct 2025 01:34:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://en.ambiotech.asia/wp-content/uploads/2021/08/cropped-Logo-Icon-32x32.png</url>
	<title>medical &#8211; AM Biotech</title>
	<link>https://en.ambiotech.asia</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.</title>
		<link>https://en.ambiotech.asia/with-outstanding-rd-achievements-and-impressive-revenue-performance-am-biotech-has-formed-a-partnership-with-the-pitdc/</link>
		
		<dc:creator><![CDATA[ambiotechadmin]]></dc:creator>
		<pubDate>Tue, 10 Sep 2024 02:03:14 +0000</pubDate>
				<category><![CDATA[Latest News]]></category>
		<category><![CDATA[Marketing Information]]></category>
		<category><![CDATA[bio-pulsed exosomes]]></category>
		<category><![CDATA[exosome]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[外泌體]]></category>
		<guid isPermaLink="false">https://en.ambiotech.asia/?p=4518</guid>

					<description><![CDATA[Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.
<p><a href="https://en.ambiotech.asia/with-outstanding-rd-achievements-and-impressive-revenue-performance-am-biotech-has-formed-a-partnership-with-the-pitdc/">Source</a></p>]]></description>
		
		
		
			</item>
	</channel>
</rss>
